Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

BACKGROUND: Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic outbreak, the number of patients can exceed maximum capacity of intensive care units (ICUs), and, thus, these individuals of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Rheumatol
Autors principals: Cavalli, Giulio, De Luca, Giacomo, Campochiaro, Corrado, Della-Torre, Emanuel, Ripa, Marco, Canetti, Diana, Oltolini, Chiara, Castiglioni, Barbara, Tassan Din, Chiara, Boffini, Nicola, Tomelleri, Alessandro, Farina, Nicola, Ruggeri, Annalisa, Rovere-Querini, Patrizia, Di Lucca, Giuseppe, Martinenghi, Sabina, Scotti, Raffaella, Tresoldi, Moreno, Ciceri, Fabio, Landoni, Giovanni, Zangrillo, Alberto, Scarpellini, Paolo, Dagna, Lorenzo
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252085/
https://ncbi.nlm.nih.gov/pubmed/32501454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(20)30127-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars